Analysis of novel cardiovascular biomarkers in patients with peripheral artery disease-Reference-Cited by-同舟云学术

Analysis of novel cardiovascular biomarkers in patients with peripheral artery disease

Published:2018-12 Issue:6 Volume:109 Page:
ISSN:0026-4806
Container-title:Minerva Medica
language:
Short-container-title:Minerva Med

Author:

Jirak Peter,Mirna Moritz,Wernly Bernhard,Paar Vera,Thieme Marcus,Betge Stefan,Franz Marcus,Hoppe Uta,Lauten Alexander,Kammler Jürgen,Schulze Paul C.,Lichtenauer Michael,Kretzschmar Daniel

Publisher

Edizioni Minerva Medica

Subject

General Medicine

Link

https://www.minervamedica.it/pdf.php?cod=R10Y2018N06A0443

Reference31 articles.

1. To screen or not to screen for peripheral arterial disease in subjects aged 80 and over in primary health care: a cross-sectional analysis from the BELFRAIL study

2. Peripheral arterial disease: prognostic significance and prevention of atherothrombotic complications;Norman PE;Med J Aust,2004

3. A Review of the Pathophysiology and Potential Biomarkers for Peripheral Artery Disease

4. Prevalence of peripheral arterial disease in subjects with moderate cardiovascular risk: Italian results from the PANDORA study Data from PANDORA (Prevalence of peripheral Arterial disease in subjects with moderate CVD risk, with No overt vascular Diseases nor Diabetes mellitus)

5. Systematic reviews and meta-analyses for more profitable strategies in peripheral artery disease

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An evaluation of inflammatory and endothelial dysfunction markers as determinants of peripheral arterial disease in those with diabetes mellitus;Scientific Reports;2024-07-03

2. An emerging view on vascular fibrosis molecular mediators and relevant disorders: from bench to bed;Frontiers in Cardiovascular Medicine;2023-12-21

3. The interplay of galectins-1, -3, and -9 in the immune-inflammatory response underlying cardiovascular and metabolic disease;Cardiovascular Diabetology;2022-11-19

4. Cardiovascular Biomarkers for Prediction of in-hospital and 1-Year Post-discharge Mortality in Patients With COVID-19 Pneumonia;Frontiers in Medicine;2022-06-28

5. Role of Extracellular Vesicles as Potential Diagnostic and/or Therapeutic Biomarkers in Chronic Cardiovascular Diseases;Frontiers in Cell and Developmental Biology;2022-01-26